Ingevity (NGVT)
(Delayed Data from NYSE)
$43.50 USD
-0.29 (-0.66%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $43.47 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Ingevity (NGVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$55.43 | $91.00 | $43.00 | 26.58% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Ingevity comes to $55.43. The forecasts range from a low of $43.00 to a high of $91.00. The average price target represents an increase of 26.58% from the last closing price of $43.79.
Analyst Price Targets (7 )
Broker Rating
Ingevity currently has an average brokerage recommendation (ABR) of 2.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.43 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, two are Strong Buy, representing 28.57% of all recommendations. A month ago, Strong Buy represented 28.57%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.43 | 2.43 | 2.43 | 2.43 | 2.43 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
1/9/2024 | Loop Capital Markets | Christopher Kapsch | Strong Buy | Hold |
11/9/2023 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
11/6/2023 | CJS Securities | Jonathan Tanwanteng | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.43 |
ABR (Last week) | 2.43 |
# of Recs in ABR | 7 |
Average Target Price | $55.43 |
LT Growth Rate | NA |
Industry | Chemical - Specialty |
Industry Rank by ABR | 62 of 252 |
Current Quarter EPS Est: | 0.07 |